Clinical Trials Sponsored by Vinnova

Total 244 results

Xintela AB
Vinnova

Recruiting

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Venous Leg Ulcer

Sweden
Region Skane
Vinnova

Completed

PHMB-based Antiseptic Use in Full-thickness Surgical Wounds

Surgical Site Infections

Sweden
Lund University
Vinnova

Completed

An Antiinflammatory Diet as Modulator of Cardiometabolic Risk and Body Weight in Healthy Subjects

Overweight | Metabolic Syndrome | Insulin Resistance

Sweden
Halmstad University
Vinnova

Completed

A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

Hypertension

Sweden
Attgeno AB
Vinnova

Withdrawn

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

COVID-19 | Pulmonary Hypertension

Sweden
Region Skane
Vinnova; Bactiguard AB

Completed

Biofilm Formation on Different Endotracheal Tube Materials

Respiratory Insufficiency | Ventilator-associated Pneumonia

Sweden
Isifer AB
Ferring Pharmaceuticals; Vinnova

Unknown

A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility

Unexplained Infertility

Poland
Mälardalen University
Danderyd Hospital; Vinnova

Completed

Mental Imagery Neurofeedback in Strokerehabilitation

Stroke | Hemiparesis

Sweden
Innova Vascular, Inc.

Not yet recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) (TRUST)

Pulmonary Embolism
Lund University
Vinnova; Öste Venture AB

Completed

Dietary Fibre and Metabolic Benefits

Glucose Tolerance

Sweden
Göteborg University
Vastra Gotaland Region; Vinnova

Completed

The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora

Hyposalivation

Sweden
VitNovo, Inc.

Completed

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Taiwan
Bio-innova Co., Ltd

Not yet recruiting

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg (DAP-030-23)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg (TIC-025-23)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg

Healthy Subjects
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Bio-innova Co., Ltd

Not yet recruiting

Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Healthy Subjects
Karolinska University Hospital
Region Stockholm; Vinnova; Eurostars

Active, not recruiting

Dysautonomia and Systemic Interactions in Traumatic Brain Injury (DYSI-TBI)

Traumatic Brain Injury | Dysautonomia | Inflammation, Brain | Sympathetic; Imbalance

Sweden
Lund University
Vinnova; Anti-Diabetic Food Centre

Completed

Impact of Meal Order on Postprandial Cardiometabolic Risk Markers

Glucose Metabolism Disorders | Metabolic Diseases | Insulin Resistance | Hyperinsulinism | Metabolic Syndrome X

Sweden
Lund University
Vinnova; Antidiabetic Food Centre AFC

Completed

Effects of Functional Ingredients in an Acute Metabolic Challenge Context

Metabolic Syndrome

Sweden
InnoRa GmbH

Completed

Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter (SCBDENOVO)

Coronary Artery Disease

Switzerland, Germany
Venova Medical

Recruiting

Early Feasibility of the Velocity™ Percutaneous pAVF System (VENOS-1)

Arteriovenous Fistula

Paraguay
InnoRa GmbH

Terminated

Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon (HYPER)

Lesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/II

Germany
InnoRa GmbH

Completed

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

Coronary Restenosis

Switzerland, Germany
InnoRa GmbH

Completed

Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon (FIMLIMUSDCB)

DES In-stent Stenosis

Malaysia
InnoRa GmbH

Completed

Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter Malaysia (SCBDNMAL)

Coronary Artery Disease

Malaysia
Vastra Gotaland Region
Sahlgrenska University Hospital, Sweden; Vinnova

Active, not recruiting

Influence on Cough and Airway Symptoms by Oral Capsaicin

Cough

Sweden
Lund University
Skane University Hospital; Vinnova; Carbiotix AB

Active, not recruiting

Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes

Diabetes Type 2

Sweden
Region Skane
Lund University; Vinnova; Innovation Skåne AB/ Sweden

Completed

Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters

Anesthesia, Local | Incontinence, Urinary | Urinary Catheters | Retention, Urinary

Sweden
Hinova Pharmaceuticals Aus Pty Ltd

Completed

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Australia
Hinova Pharmaceuticals Inc.

Recruiting

A Phase I Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Metastatic Castration-resistant Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Metastatic Castration Resistant Prostate Cancer

China
Hinova Pharmaceuticals Inc.

Completed

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Metastatic Castration Resistant Prostate Cancer

China
Innovo Therapeutics, Inc.

Recruiting

Ointment to Prevent Scar After Thyroidectomy

Scar

Korea, Republic of
Hinova Pharmaceuticals Inc.

Recruiting

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

mCRPC

China
Innovo Therapeutics, Inc.

Completed

First in Human, Single Ascending Dose Study

Ulcerative Colitis

Korea, Republic of
BioNova Pharmaceuticals (Shanghai) LTD.

Completed

Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)

GVHD, Chronic

China
Hospital Arnau de Vilanova

Completed

Carbohydrate Restriction for Gestational Diabetes Mellitus (LO-CA)

Gestational Diabetes Mellitus (GDM)

Spain
Hospital Arnau de Vilanova

Unknown

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Non-Small Cell Lung Cancer

Spain

3

Subscribe